co.don AG
ISIN: DE000A3E5C08 | Ticker: CNW
Country: Germany
CO.DON AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells ("autologous chondrocytes"). CO.DON's method is currently used in over 200 clinics in Germany and more than 17,000 patients have already been treated. In July 2017 CO.DON AG received central EU marketing authorisation for this product. At the Leipzig site, CO.DON has built one of the largest and most modern facilities for the production of human cells on an industrial scale for in-house and contract manufacturing.
Year founded1993
Served areaEurope
Headcount117
HeadquartersWarthestraße 21, 14513 Teltow – Germany
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 21.10.21 | Günther, Bernd | Supervisory board | Buy | EUR 35.84 |
| 20.10.21 | Laik, Robin | Board | Other | EUR 10,348,300.00 |
| 20.10.21 | ELBER GmbH | Close relation | Other | EUR 10,179,000.00 |
| 20.10.21 | Rofalski, Volker | Supervisory board | Other | EUR 292,500.00 |
| 20.10.21 | Müller, Dr. Axel | Supervisory board | Other | EUR 195,000.00 |
| 20.10.21 | Laumann, Johannes | Board | Other | EUR 131,625.00 |
| 20.10.21 | Laik, Louisa | Close relation | Other | EUR 129,987.00 |
| 20.10.21 | Laik, Daniel | Close relation | Other | EUR 97,500.00 |
| 20.10.21 | Friedrich, Neela | Close relation | Other | EUR 64,993.50 |
| 20.10.21 | Schleede, Dr. Kristian | Board | Other | EUR 29,250.00 |
DE000A3E5C08
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.